Menu
Annual · values202520242023202220212019201820172016201420132012
Operating Cash Flow24.53 B USD24.27 B USD22.79 B USD23.41 B USD23.54 B USD23.42 B USD22.20 B USD21.06 B USD19.28 B USD18.47 B USD17.41 B USD15.40 B USD
Depreciation & Amortization7.50 B USD7.34 B USD7.49 B USD7.39 B USD7.23 B USD7.01 B USD6.93 B USD5.64 B USD3.75 B USD3.90 B USD4.10 B USD3.67 B USD
Stock-Based Compensation1.35 B USD1.18 B USD1.16 B USD1.14 B USD1.00 B USD977.00 M USD978.00 M USD962.00 M USD874.00 M USD792.00 M USD728.00 M USD662.00 M USD
Capital Expenditures4.83 B USD4.42 B USD4.54 B USD3.65 B USD3.35 B USD3.50 B USD3.67 B USD3.28 B USD3.46 B USD3.71 B USD3.60 B USD2.93 B USD
Cash Flow from Investing-23.59 B USD-18.60 B USD878.00 M USD-8.68 B USD-20.82 B USD-6.19 B USD-3.17 B USD-14.87 B USD-7.74 B USD-12.30 B USD-5.10 B USD-4.51 B USD
Cash Flow from Financing-5.54 B USD-3.13 B USD-15.82 B USD-14.05 B USD-6.12 B USD-18.02 B USD-18.51 B USD-7.67 B USD-10.85 B USD-12.26 B USD-6.09 B USD-20.56 B USD
Dividends Paid
Stock Buybacks5.95 B USD2.43 B USD5.05 B USD3.46 B USD3.22 B USD6.75 B USD5.87 B USD6.36 B USD5.29 B USD7.12 B USD3.54 B USD12.92 B USD
Free Cash Flow19.70 B USD19.84 B USD18.25 B USD19.76 B USD20.19 B USD19.92 B USD18.53 B USD17.78 B USD15.82 B USD14.76 B USD13.82 B USD12.46 B USD

Johnson & Johnson is a holding company engaged in the research, development, manufacture, and sale of healthcare products worldwide. It operates through two primary segments: Innovative Medicine, which focuses on pharmaceuticals including treatments for immunology, oncology, infectious diseases, neuroscience, cardiovascular and metabolic disorders, and pulmonary hypertension; and MedTech, which provides advanced surgical equipment, devices for orthopaedics, vision care, and solutions for robotics, navigation, and digital technologies. The company delivers innovative medicines and medical technologies that address unmet patient needs across diverse therapeutic areas, supporting healthcare professionals and consumers globally. Johnson & Johnson plays a pivotal role in the healthcare sector by advancing medical innovation and improving health outcomes through its broad portfolio of branded products and services. Founded in 1887 and headquartered in New Brunswick, New Jersey, it remains a cornerstone of the global health technology and pharmaceuticals industry.